A novel discovery in the field of pancreatic cancer treatment has been unveiled, revealing the epigenetic silencing of BEND4 as a potential synthetic ...

Along with defending against pathogens, the body’s innate immune system helps to protect the stability of our genomes in ...

Derek Urwin has a special stake in his work as a cancer control researcher. After undergraduate studies in applied ...

Along with defending against pathogens, the body's innate immune system helps to protect the stability of our genomes in unexpected ways -- ways that have important implications for the development of ...

These chemicals appear to evade DNA repair mechanisms, making it harder for our cells to undo the damage they cause.

Along with defending against pathogens, the body's innate immune system helps to protect the stability of our genomes in ...

Researchers from IACS Kolkata have identified TDP1 as a potential target for cancer therapy, offering hope for overcoming ...

Researchers have discovered key mutations in certain cancer cells that make them resistant to WRN inhibitors, a new class of ...

Merck’s acquisition of Modifi Biosciences will give it access to preclinical cancer drug candidates that target DNA repair ...

MSD has acquired US cancer therapeutics developer Modifi Biosciences, a Yale University spinout, enhancing its portfolio with ...

University of Oregon biologists have uncovered a mechanism by which a well-known breast cancer gene also influences fertility. Mutations in the BRCA1 gene sharply increase a person's risk of ...

Merck & Co. is putting down $30 million cash to buy Yale spinout Modifi Biosciences, a deal that includes a preclinical asset ...